share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Kane Brian A

CVS Health | 4: Statement of changes in beneficial ownership of securities

西維斯健康 | 4:持股變動聲明
SEC announcement ·  04/04 05:03
牛牛AI助理已提取核心訊息
Brian A. Kane, EVP/President of Aetna at CVS Health, was granted 12,569 restricted shares of CVS Health Common Stock on April 1, 2024. The transaction, which was completed on the same day, was a grant of shares with no transaction price, indicating that the shares were likely awarded as part of executive compensation. Following the transaction, Kane directly holds a total of 12,569 shares in the company. The grant is part of the company's ongoing incentive plans for its executives and is a standard practice in aligning the interests of management with those of shareholders.
Brian A. Kane, EVP/President of Aetna at CVS Health, was granted 12,569 restricted shares of CVS Health Common Stock on April 1, 2024. The transaction, which was completed on the same day, was a grant of shares with no transaction price, indicating that the shares were likely awarded as part of executive compensation. Following the transaction, Kane directly holds a total of 12,569 shares in the company. The grant is part of the company's ongoing incentive plans for its executives and is a standard practice in aligning the interests of management with those of shareholders.
2024年4月1日,CVS Health安泰執行副總裁兼總裁布萊恩·凱恩獲得了12,569股CVS Health普通股的限制性股份。該交易於當天完成,是授予股票,沒有交易價格,這表明這些股票很可能是作爲高管薪酬的一部分授予的。交易完成後,凱恩直接持有該公司總計12,569股股份。該補助金是公司針對其高管的持續激勵計劃的一部分,也是使管理層利益與股東利益保持一致的標準做法。
2024年4月1日,CVS Health安泰執行副總裁兼總裁布萊恩·凱恩獲得了12,569股CVS Health普通股的限制性股份。該交易於當天完成,是授予股票,沒有交易價格,這表明這些股票很可能是作爲高管薪酬的一部分授予的。交易完成後,凱恩直接持有該公司總計12,569股股份。該補助金是公司針對其高管的持續激勵計劃的一部分,也是使管理層利益與股東利益保持一致的標準做法。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。